Abstract
Testicular cancer is an important disease affecting young men. The overall 5-year survival has improved to 95%. The goal now is to maintain the efficacy of treatment in advanced disease while reducing the associated side effects.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Algorithms
-
Antineoplastic Agents / adverse effects
-
Humans
-
Lymph Node Excision / adverse effects
-
Male
-
Neoplasm Staging / methods
-
Prognosis
-
Risk Factors
-
Testicular Neoplasms* / epidemiology
-
Testicular Neoplasms* / pathology
-
Testicular Neoplasms* / therapy